References
- Barrett, B., Byford, S., & Knapp, M. (2005). Evidence of cost-effective treatments for depression: A systematic review. Journal of Affective Disorders, 84, 1–13.
- Basu, A. (2004). Cost-effectiveness analysis of pharmacological treatments in schizophrenia: Critical review of results and methodological issues. Schizophrenia Research, 71, 445–462.
- Davis, J., Chen, N., & Glick, I. (2003). A meta-analysis of the efficacy of second-generation anti-psychotics. Archives of General Psychiatry, 60, 553–564.
- Jonsson, L., Jonsson, B., & Wimo, A. (2002). Costs of dementia In M. Maj & N. Sartorius (Eds), Dementia. Chichester: Wiley.
- Knapp, M., Mangalore, R., & Simon, J. (2004). The global costs of schizophrenia. Schizophrenia Bulletin, 30, 279 — 293.
- McCrone, P., Knapp, M., Proudfoot, J., Ryden, C., Cavanagh, K., Shapiro, D., Ilson, S., Gray, J., Goldberg, D., Mann, A., Marks, I., Everitt, B., & Tylee, A. (2004). Cost-effectiveness of computerised cognitive—behavioural therapy for anxiety and depression in primary care: Randomised controlled trial, British Journal of Psychiatry, 185, 55 — 62.
- Romeo, R., Byford, S., & Knapp, M. (2005). Economic evaluations of child and adolescent mental health interventions: A systematic review. Journal of Child Psychology and Psychiatry, forthcoming.
- Sainsbury Centre for Mental Health (2003). The economic and social costs of mental illness. London: SCMH. Simpson, A., Miller, C., & Bowers, L. (2003). Case management models and the care programme approach: how to make the CPA effective and credible. Journal of Psychiatric and Mental Health Nursing, 10, 472 — 483.
- Thomas, C., & Morris, S. (2003). The cost of depression among adults in England in 2000. British Journal of Psychiatry, 183, 514–519.
- World Health Organization (2003) Investing in Mental Health. Geneva: World Health Organization.